New Research Reveals Imaging with Siemens' Artis zeego Can Improve
Chemoembolization Procedures for Interventional Radiologists
WASHINGTON, March 17 /PRNewswire/ -- New research released at the Society of Interventional Radiology's (SIR) Annual Scientific Meeting in Washington, D.C., this week, holds promise of a new interventional imaging capability using advanced robotics provided by Siemens Healthcare (http://www.siemens.com/healthcare), to improve the value of chemoembolization in treating cancer.
The research, presented by Dr. John Angle, Associate Professor of Radiology, Chief, Division of Angiography, University of Virginia Health System in Charlottesville, at the "Advanced Imaging Symposium," reveals clinical results from his case study using the Siemens Artis zeego(R), a multi-axis C-arm that employs robotic technology to enable large-volume syngo(R) DynaCT acquisition for liver chemoembolization.
The Artis zeego is part of the new Artis zee(R) family of interventional imaging systems introduced by Siemens. Siemens is showcasing the Artis zee family at the SIR meeting in Booth #833. Additionally, Dr. Michael J. Wallace from the University of Texas M. D. Anderson Cancer Center in Houston and Dr. Ralf Hofmann from the University of Munich in Germany presented case studies using Artis zee solutions at the symposium.
According to Angle, the combination of the Artis zeego and large-volume syngo(R) DynaCT enables the physician to see the whole abdomen or the entire liver for chemoembolization and biopsies, and provides reliable post-TACE assessment of lipidol uptake.
"The Artis zeego's support for expanded syngo DynaCT anatomical
coverage enables the entire liver to be imaged without moving the
|SOURCE Siemens Healthcare|
Copyright©2008 PR Newswire.
All rights reserved